Epstein barr virus encodes miRNAs to assist host immune escape
Journal of Cancer2020Vol. 11(8), pp. 2091–2100
Citations Over TimeTop 13% of 2020 papers
Abstract
Epstein-barr virus (EBV) is a definite tumorigenic virus, which can form life-long latency in the host, which is difficult to be recognized and completely eliminated by the immune system. It is closely related to the occurrence and development of nasopharyngeal cancer, gastric cancer and various types of lymphoma. At present, a total of 44 Epstein-barr virus-encoded microRNAs (EBV miRNAs) have been found. In response to the immune system of the body, EBV miRNAs can inhibit the expression and presentation of viral antigens, inhibit immune activation and immunotoxicity, assisting host cells to escape from immunity, and providing conditions for further immortalized tumorigenesis of the host cells.
Related Papers
- → Functions and mechanisms of miR-186 in human cancer(2019)75 cited
- → Impact of microRNA dynamics on cancer hallmarks: An oral cancer scenario(2017)63 cited
- → Epstein Bar Virus—The Cause of Hodgkin’s Lymphoma(2018)13 cited
- → Central-Nervous-System Lymphoma Related to Epstein–Barr Virus(1983)206 cited
- → Association between Epstein-Barr Virus and Classic Hodgkin Lymphoma in Jordan: A Comparative Study with Epstein-Barr Virus-associated Hodgkin Lymphoma in North America(2004)13 cited